These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30154152)

  • 1. A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.
    Koifman G; Shetzer Y; Eizenberger S; Solomon H; Rotkopf R; Molchadsky A; Lonetto G; Goldfinger N; Rotter V
    Cancer Res; 2018 Oct; 78(20):5833-5847. PubMed ID: 30154152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy.
    Lonetto G; Koifman G; Silberman A; Attery A; Solomon H; Levin-Zaidman S; Goldfinger N; Porat Z; Erez A; Rotter V
    Cell Death Differ; 2019 Sep; 26(9):1566-1581. PubMed ID: 30413783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-324-5p-CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness.
    Ghatak D; Datta A; Roychowdhury T; Chattopadhyay S; Roychoudhury S
    Mol Cancer Res; 2021 Oct; 19(10):1635-1650. PubMed ID: 34257080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
    Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
    Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
    Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
    Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Solomon H; Dinowitz N; Pateras IS; Cooks T; Shetzer Y; Molchadsky A; Charni M; Rabani S; Koifman G; Tarcic O; Porat Z; Kogan-Sakin I; Goldfinger N; Oren M; Harris CC; Gorgoulis VG; Rotter V
    Oncogene; 2018 Mar; 37(12):1669-1684. PubMed ID: 29343849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.
    Chung WC; Zhang S; Challagundla L; Zhou Y; Xu K
    Neoplasia; 2017 Nov; 19(11):885-895. PubMed ID: 28938159
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Watanabe S; Tsuchiya K; Nishimura R; Shirasaki T; Katsukura N; Hibiya S; Okamoto R; Nakamura T; Watanabe M
    Mol Cancer Res; 2019 Jul; 17(7):1459-1467. PubMed ID: 30988165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
    Shetzer Y; Molchadsky A; Rotter V
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27235476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
    Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
    Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.
    Houghton J; Li H; Fan X; Liu Y; Liu JH; Rao VP; Poutahidis T; Taylor CL; Jackson EA; Hewes C; Lyle S; Cerny A; Bowen G; Cerny J; Moore N; Kurt-Jones EA; Erdman SE
    Stem Cells Dev; 2010 Aug; 19(8):1153-66. PubMed ID: 20199238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
    Liu T; Wu X; Chen T; Luo Z; Hu X
    Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
    [No Abstract]   [Full Text] [Related]  

  • 17. ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
    Tsai ST; Wang PJ; Liou NJ; Lin PS; Chen CH; Chang WC
    PLoS One; 2015; 10(11):e0142834. PubMed ID: 26571024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Gain-of-Function Activity of Three p53 Hotspot Mutants In Vivo.
    Xiong S; Chachad D; Zhang Y; Gencel-Augusto J; Sirito M; Pant V; Yang P; Sun C; Chau G; Qi Y; Su X; Whitley EM; El-Naggar AK; Lozano G
    Cancer Res; 2022 May; 82(10):1926-1936. PubMed ID: 35320355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells.
    Armesilla-Diaz A; Elvira G; Silva A
    Exp Cell Res; 2009 Dec; 315(20):3598-610. PubMed ID: 19686735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.
    Vogiatzi F; Brandt DT; Schneikert J; Fuchs J; Grikscheit K; Wanzel M; Pavlakis E; Charles JP; Timofeev O; Nist A; Mernberger M; Kantelhardt EJ; Siebolts U; Bartel F; Jacob R; Rath A; Moll R; Grosse R; Stiewe T
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8433-E8442. PubMed ID: 27956623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.